PAR 2.63% 19.5¢ paradigm biopharmaceuticals limited..

PAR 7 & Psoriasis, page-28

  1. jtl
    85 Posts.
    lightbulb Created with Sketch. 35
    Thanks Mozzarc, appreciate your input.
    Like you I believe we are well ahead of the competition, especially with disclosures like this:

    GLPG1972/S201086 is an investigational drug, and its efficacy and safety have not been established.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.